研究单位：[1]Chia Tai Tianqing Pharmaceutical Group Co., Ltd.[2]Beijing Cancer Hospital Beijing, Beijing, China, 100142[3]The 307th Hospital of Chinese People's Liberation Army Beijing, Beijing, China[4]Chongqing Daping Hospital Chongqing, Chongqing, China, 400042[5]Union Hospital of Fujian Medical University Fuzhou, Fujian, China, 350001[6]Fujian Cancer Hospital Fuzhou, Fujian, China[7]Lanzhou General Hospital Lanzhou, Gansu, China, 730070[8]Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060[9]The People's Hospital of Guangxi Zhuang Autonomous Region Nanning, Guangxi, China, 530021[10]Fourth Hospital of Hebei Medical University Tumor Hospital of Hebei Province Shijiazhuang, Hebei, China, 050011河北医科大学第四医院[11]Harbin medical university affiliated tumor hospita Harbin, Heilongjiang, China[12]Henan Province Tumor Hospital Luoyan, Henan, China[13]The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China, 450052[14]Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China, 430022[15]Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China, 430030[16]Xiangya Hospital Central South University Changsha, Hunan, China, 410008[17]The Third Xiangya Hospital Central South University Changsha, Hunan, China, 410013[18]Hunan Province Tumor Hospital Changsha, Hunan, China[19]The General Hospital of Nanhua University Hengyang, Hunan, China, 421001[20]The First People's Hospital of Changzhou Changzhou, Jiangsu, China, 213003[21]Jiangsu Cancer Hospital Nanjing, Jiangsu, China[22]Jiangsu Province Hospital Nanjing, Jiangsu, China[23]Nantong Cancer Hospital Nantong, Jiangsu, China[24]The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China, 330006[25]The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China, 330006[26]Jiangxi Cancer Hospital Nanchang, Jiangxi, China[27]Jilin Cancer Hospital Changchun, Jilin, China, 132000[28]Liaoning Province Tumor Hospital Shenyang, Liaoning, China[29]Shandong Tumor Hospital Jinan, Shandong, China, 250117[30]Linyi City Tumor Hospita Linyi, Shandong, China[31]Fudan University Zhongshan Hospital Shanghai, Shanghai, China, 200032[32]Shanghai General Hospital Shanghai, Shanghai, China, 200080[33]Cancer Hospital of Fudan University Shanghai, Shanghai, China[34]Tangdu Hospital of The fourth Military Medical University Xian, Shanxi, China[35]Tianjin Medical University Cancer Hospital Tianjin, Tianjin, China[36]Tianjin Medical University General Hospital Tianjin, Tianjin, China[37]Yunnan Province Tumor Hospital Kunming, Yunnan, China[38]Sir Run Run Shaw Hospital School of Medical,Zhejiang University Hangzhou, Zhejiang, China, 310016[39]The First Affiliated Hospital, Anhui Medical University Hefei, Anhui, China
研究目的：
The purpose of this study is to compare the effects and safety of Anlotinib with placebo in patients with Gastric Cancer.
